ConductScience.org, home

Paper55599

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.

Marsden CD and 1 other. Lancet, 1976. Cited by 651 papers, by iCite.

Cite this record

ConductScience Library. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Papers, record 55599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55599

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
651
iCite
Relative citation ratio, by iCite
21.3
iCite
Revised in PubMed
2022-03-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marsden CDC D
2Parkes JDJ D

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LevodopaMajor topic
Movement DisordersMajor topic
Muscle RigidityMajor topic
Parkinson DiseaseMajor topic
Dose-Response Relationship, Drug
Half-Life
Long-Term Care
Time Factors

Source PubMed

Download CSV of topics

Cited by136

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 651 citations.

PMIDTitleJournalYearIn PapersSource
42965636Subcutaneous apomorphine and the nonmotor features of Parkinson's disease.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/42965636PubMed
42931251Two Coordinates for Dopamine in the Basal Ganglia.NeuroSci2026https://conductscience.org/library/papers/42931251PubMed
42465309Device-embedded accelerometry complements neural signals for tracking parkinsonian motor states.bioRxiv2026https://conductscience.org/library/papers/42465309PubMed
42268283Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment.J Parkinsons Dis2026https://conductscience.org/library/papers/42268283PubMed
41745405Protection Against Cellular Toxicity from Rotenone Treatment by the Neuroprotective, Novel Multifunctional Antiparkinsonian Drug D-512.J Pers Med2026https://conductscience.org/library/papers/41745405PubMed
41374647AI-Driven Analysis of Wrist-Worn Sensor Data for Monitoring Individual Treatment Response and Optimizing Levodopa Dosing in Parkinson's Disease.Sensors (Basel)2025https://conductscience.org/library/papers/41374647PubMed
40719828Motor and non-motor fluctuations in Parkinson's disease: the knowns and unknowns of current therapeutic approaches.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/40719828PubMed
40082320Non-motor fluctuations in Parkinson's disease: frequency and clinical correlate.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/40082320PubMed
39703981Non-Motor Fluctuations in Parkinson's Disease: Underdiagnosed Yet Important.J Mov Disord2025https://conductscience.org/library/papers/39703981PubMed
39047295Levodopa: From Biological Significance to Continuous Monitoring.ACS Sens2024https://conductscience.org/library/papers/39047295PubMed
38774174Assessment of Pulmonary Functions in Parkinson's Disease and Unveiling the Role of Levodopa Therapy: A Cross-Sectional Study.Cureus2024https://conductscience.org/library/papers/38774174PubMed
38747222Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.Curr Diabetes Rev2025https://conductscience.org/library/papers/38747222PubMed
38537648Ophthalmate is a new regulator of motor functions via CaSR: implications for movement disorders.Brain2024https://conductscience.org/library/papers/38537648PubMed
38404670Mixed-Response State-Space Model for Analyzing Multi-Dimensional Digital Phenotypes.J Am Stat Assoc2023https://conductscience.org/library/papers/38404670PubMed
36571976Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein.Bioorg Med Chem2023https://conductscience.org/library/papers/36571976PubMed
36141268Wrist Movement Variability Assessment in Individuals with Parkinson's Disease.Healthcare (Basel)2022https://conductscience.org/library/papers/36141268PubMed
35774903Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes.Health Psychol Res2022https://conductscience.org/library/papers/35774903PubMed
35342258The Story of Levodopa: A Long and Arduous Journey.Ann Indian Acad Neurol2022https://conductscience.org/library/papers/35342258PubMed
35110492Recent Advances in Drug Therapy for Parkinson's Disease.Intern Med2023https://conductscience.org/library/papers/35110492PubMed
35043355Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson's disease?Neurol Sci2022https://conductscience.org/library/papers/35043355PubMed

See all 136 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55599

GET https://conductscience.org/api/papers/v1/55599/cited_by?page=2